Finance entity
earnings is the sole category represented across all 1 tracked stories. Chemed Corporation is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window.
Last mentioned: Feb 25, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
earnings is the sole category represented across all 1 tracked stories. Chemed Corporation is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 5.7. We currently track 1 Finance story that mention VITAS Healthcare, all published on February 25, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 96 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering VITAS Healthcare. Shared-story counts are live from our verified record — not editorial picks.
Zevia and Chemed both reported fourth-quarter revenue that fell short of analyst expectations, leading to significant stock price declines. While Zevia managed a slight EPS beat, Chemed saw a dramatic 14.7% plunge as investors prioritized top-line growth and guidance over narrow margin improvements.
VITAS Healthcare is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
